Our company and Beijing Kaijin Technology Co., Ltd. held a signing ceremony for the research and development project of Class 1 traditional Chinese medicine innovative medicine Houwuqing Capsule and Shugan Ningshen Dropping Pills.

On November 19, 2022, the signing ceremony of Guizhou ruihe pharmaceutical co., ltd. and Beijing kaijin technology co., ltd. and Shanxi jianshuo food and drug research institute co., ltd. for class 1 traditional Chinese medicine innovative medicine throat clear capsule and shugan ningshen drop pill project was held in the conference room of Guizhou ruihe pharmaceutical co., ltd.

Luo Chunxiu, General Manager and Li Xianrong of Beijing Kaijin Technology Co., Ltd./Shanxi Jianshuo Food and Drug Research Institute, Xiong Yigang, Chairman of Guizhou Ruihe Pharmaceutical Co., Ltd., Zhao Yun, General Manager, Zhang Yun, Deputy General Manager, Chen Yuyou, Secretary of the Board of Directors, and He Feng, Director of Research and Development Department, attended the signing ceremony.

Beijing Kaijin Technology Co., Ltd./Shanxi Jianshuo Food and Drug Research Institute has platforms for the research and development of innovative traditional Chinese medicines and famous prescriptions, classic prescriptions and formula granules, and the development of new foods and health foods. It has rich experience in the research and development of new traditional Chinese medicines and technology transfer. Guizhou Ruihe Pharmaceutical Co., Ltd. has the strength and channels to rapidly promote the commercialization and industrialization of drugs. This time, the two sides reached a cooperation intention to cooperate in the development of two projects of Class 1 Chinese medicine innovative drug Haoqing Capsule and Shugan Ningshen Dropping Pills.

Before the signing ceremony, Luo chunxiu, general manager of Beijing kaijin technology co., ltd./Shanxi jianshuo food and drug research institute, introduced the basic situation of class 1 traditional Chinese medicine new-creation drug hou yin Qing capsule and shugan ningshen drop pill products, the risk points existing in the project development and the risk control measures. Haoyaoqing capsule is obtained by adding and subtracting the ancient prescription "Haozi Decoction" and "Platycodon grandiflorum Decoction". Its main functions are clearing lung and detoxifying, nourishing yin and reducing fire, and establishing throat and opening sound. It is used for acute laryngitis with lung heat accumulation syndrome. The symptoms include hoarseness, dry throat, burning heat and pain, redness and swelling of laryngeal portal muscle membrane, red tongue, yellow moss, pulse number, etc. Shugan Ningshen dripping pills are obtained by adding and subtracting "Chaihu Shugan San" in Jingyue Quanshu. The main function is to soothe liver and regulate qi, relieve depression and Ningshen. For liver qi stagnation type insomnia.

The two sides had in-depth exchanges on the risk points, risk control measures and follow-up technology transfer in the development of the projects of Haoqing Capsule and Shugan Ningshen Dropping Pills, especially the scheme design, selection of indications and marketing of Haoqing Capsule after its listing. The research and development of two Class 1 innovative Chinese medicine drugs will help enrich the company's product structure and have a significant impact on the future product strategic layout. The two sides jointly uphold the principle of "consistent goals, unified understanding, and win-win cooperation". The two sides give full play to their respective advantages, expand cooperation areas, innovate cooperation models, and develop innovative Chinese medicine, and strive to achieve "scientific and technological innovation cooperation, production and research win-win".

Finally, Mr. Xiong once again expressed his gratitude to President Li, Mr. Luo and his entourage, and said that he would further strengthen corporate exchanges and cooperation, give full play to the advantages of both parties, and continue to cooperate in the development of classic Chinese medicine, innovative Chinese medicine and market value on the basis of strategic cooperation. Functional food, health food and other large healthy varieties.